Latest KFF Health News Stories
Lack Of Medicaid Expansion Hurts Rural Hospitals More Than Urban Facilities
Researchers writing in Health Affairs report that decisions by 19 states to not expand the program for low-income residents could be hurting the financial stability of rural hospitals.
Study Says Concerns About Orphan Drug Spending Are Unjustified
A study in Health Affairs concludes that orphan drugs for rare diseases are not having a widespread or deep impact on health care spending.
EpiPen Controversy Fuels Concerns Over Generic Drug Approval Backlog
Four years after a huge push to speed generics to market, the FDA has more than 4,000 generics waiting for approval.
Under a new state law, California consumers could get money back if they were charged out-of-network prices after going to a medical provider who was listed in their health plan’s network.
Gaps In Care Persist During Transition From Hospital To Home
A partnership between San Diego County and four health systems seeks to bridge the longstanding gap between hospitals and social services.
Attending To The ‘Human Element’ Is Key To Keeping Patients Healthy
Research to be published in full this fall details how medicine’s “implicit bias” — whether real or perceived — undermines the doctor-patient relationship and the well-being of racial and ethnic minorities as well as lower-income patients.
What Happens When A Living Kidney Donor Needs A Transplant?
A new study examines how well efforts are working that prioritize the needs of these patients if they end up needing a kidney transplant of their own.
Mylan’s Generic EpiPen — A Price Break Or Marketing Maneuver?
As news that Mylan will make available a generic version of its own brand-name product, KHN answers key questions about how this development could affect consumers.
‘America’s Other Drug Problem’: Copious Prescriptions For Hospitalized Elderly
Older people are often given a huge number of medications, and many of them are unnecessary or even harmful.
Patients, Fearing Pricey Follow-Ups, May Shy Away From Some Colon Cancer Tests
Most screening tests for colon cancer are covered by insurance but if they come back positive, they may require a diagnostic colonoscopy and that may not be covered completely by insurance.
FAQ: Hospital Observation Care Can Be Costly For Medicare Patients
A guide to help Medicare patients receiving observation care.
Infant Gas Relief Drops, Often Added To Medical Scopes, May Pose Danger
In a small study, Minnesota researchers found that the infant drops used to increase visibility during procedures may create a “perfect habitat” for bacteria and make scopes harder to clean.
Doctors Raise Concerns For Small Practices In Medicare’s New Payment System
The government is laying out plans to use payment incentives to promote higher quality care, but physicians say the new system may be hard on solo practices and small groups.
Geriatric ERs Reduce Stress, Medical Risks For Elderly Patients
Overcrowding and chaos in traditional emergency rooms can harm seniors’ health. That’s prompting some hospitals to open ERs designed specifically for the elderly.
Public Health Officials Struggle To Identify Sepsis Before It Becomes Deadly
Consumer campaigns, hospital rules and some new state laws seek to increase awareness about the lethal disease.
Who’s Affected By Insurers’ Pullbacks And What It Could Mean For The ACA’s Future
Health insurance giant Aetna will stop selling insurance through most state exchanges created by the Affordable Care Act. It’s the third major insurer to pull back from Obamacare. Who’s affected and what this means for the future of the ACA.
Doctors, Hospitals Prepare For Difficult Talks Surrounding Medical Mistakes
MedStar Health is among the hospital systems nationwide that are setting up support systems to help doctors talk openly to patients and their families when treatments go awry.
Obamacare Marketplace Shakeout Rocks Arizona, Southeast
Fewer choices in 2017 health care plans await consumers in dozens of markets where Aetna, UnitedHealthcare and Humana are pulling out, but withdrawals may hit Arizona, the Carolinas, Georgia and parts of Florida hardest.
California Lawmaker Pulls Plug On Drug Price Transparency Bill
The legislation would have required drug companies to notify the state and insurers about expensive new treatments or price hikes.
Genetic Insights About Health Risks Limited By Lack Of Diversity, Study Finds
A study in the New England Journal of Medicine detailed how the diagnoses of risk for a common hereditary heart disease may have been skewed because studies have traditionally had low numbers of black participants.
